BackArbutus Biopharma Overview

Arbutus Biopharma Total Revenue

Revenue analysis for ABUS.

Quarterly Revenue

$179.13M
10054.54% YoY

As of Mar 2026

Annual Revenue (TTM)

$191.44M
2889.93% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading